The New Way Big Pharma is Trying to Rip Us All Off

 Thom Harttman -  Molnupiravir is the new pill that’s been all over the news recently because it can cut hospitalizations and deaths of unvaccinated Covid-infected people by as much as half and doesn’t require folks to go to the hospital or an infusion center, like the monoclonal antibody treatment.  Just take four pills every day for five days and you’re good. It was originally developed by Emory University to treat horses infected with Venezuelan equine encephalitis with a $10 million grant from the Department of Defense and an additional $19 million from the National Institutes of Health. In other words, its invention was paid for with our tax dollars....

Manufacturing cost for molnupiravir, according to a report from researchers with the Harvard School of Public Health, is around $17.74 for a 5-day course of treatment. Merck signed a contract in 2021 with the federal government to sell 1.7 million treatment courses to the federal and (and via the feds) to state governments to distribute to infected people for — wait for it — $712.00 each.